271 Matching Annotations
  1. Aug 2022
  2. Apr 2022
    1. Jackie Parchem, MD [@jackie_parchem]. (2021, July 29). @MeadowGood @ACOGPregnancy Some of the docs who stepped up and got vaccinated early when we didn’t have the data we do now. What we all knew: Protecting moms protects babies! All have had their babies by now! @IlanaKrumm @anushkachelliah @gumbo_amando @emergjenncy @JuliaNEM33 https://t.co/h9UJo6h3fQ [Tweet]. Twitter. https://twitter.com/jackie_parchem/status/1420785474499645442

    1. Carl T. Bergstrom. (2021, August 18). 1. There has been lots of talk about recent data from Israel that seem to suggest a decline in vaccine efficacy against severe disease due to Delta, waning protection, or both. This may have even been a motivation for Biden’s announcement that the US would be adopting boosters. [Tweet]. @CT_Bergstrom. https://twitter.com/CT_Bergstrom/status/1427767356600688646

  3. Mar 2022
    1. ReconfigBehSci on Twitter: ‘@alexdefig are you really going to claim that responses to the introduction of passports on uptake across 4 other countries are evidentially entirely irrelevant to whether or not passports are justified or not?’ / Twitter. (n.d.). Retrieved 31 March 2022, from https://twitter.com/SciBeh/status/1444358068280565764

    1. Eran Segal. (2021, August 17). Israel data showing the decay of vaccine efficacy over time. Y-axis is cases per 1000 from July 7 to Aug 10, for unvaccinated, and for people vaccinated at different times Cases are higher in those vaxed earlier Despite world-data caveats, this seems quite compelling https://t.co/5aNz48AC8F [Tweet]. @segal_eran. https://twitter.com/segal_eran/status/1427696623988117505

    2. Natalie E. Dean, PhD. (2021, August 17). Real-world data from Israel show a growing gap between the earliest vaccinated (blue arrow) and the recently vaccinated (green arrow) within age groups. Confounding is always a concern (are these groups fundamentally different?) but the magnitude of the difference is notable. Https://t.co/s8pevRbax8 [Tweet]. @nataliexdean. https://twitter.com/nataliexdean/status/1427703094062706691

  4. Feb 2022
    1. Altarawneh, H. N., Chemaitelly, H., Hasan, M. R., Ayoub, H. H., Qassim, S., AlMukdad, S., Coyle, P., Yassine, H. M., Al-Khatib, H. A., Benslimane, F. M., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., … Abu-Raddad, L. J. (2022). Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMc2200133

    1. Eric Feigl-Ding. (2022, January 17). Pandemic leadership matters. #COVID19 mortality per capita by state. 📍Public health is policy, policy is politics. 📍Human behavior is often driven by misinformation. 📍Misinformation is often driven by politics. 📍Politics can be changed by voting—Unless voters can’t. Https://t.co/pFkndQZrfr [Tweet]. @DrEricDing. https://twitter.com/DrEricDing/status/1483181226815012867

    1. APPG on Coronavirus. (2022, January 18). 🗣Dr.Claire Steves continued: “Looking in the national core studies, from cohort studies across the UK we’ve looked at 10 different longitudinal studies. Our best estimates are that about 5% of middle aged people are experiencing long term.. 27/ #APPGCoronavirus #LongCovid [Tweet]. @AppgCoronavirus. https://twitter.com/AppgCoronavirus/status/1483453895061999618

    1. F. Perry Wilson, MD MSCE. (2022, February 4). If you, like me, are “skipping ahead” during the ACIP meeting re: Moderna vaccine—This slide really drives home the benefit / risk paradigm among the group at highest risk of myocarditis (men 18-35). 2 million shots = 1903 avoided hospitalizations, and 68 myocarditis cases. Https://t.co/3nzWXGXyD1 [Tweet]. @fperrywilson. https://twitter.com/fperrywilson/status/1489649379979972609

    1. Krutika Kuppalli, MD FIDSA. (2022, January 14). If you had #COVID19 once you can get it again (and again). Risk of reinfection in England with #Omicron was ~5.4 fold higher compared to #Delta The relative risk were 6.36 & 5.02 for unvaxxd & vaxxd cases—Implies protection against reinfection by Omicron may be as low as 19% [Tweet]. @KrutikaKuppalli. https://twitter.com/KrutikaKuppalli/status/1482074117742288898

    1. Viki Male on Twitter: “@jtmayes3 @kevinault Let’s begin by taking the 172,000 number at face value. About 190,000 ppl have been vaccinated during pregnancy in the US. So if that were true it’s a miscarriage rate of 90%… 1/ https://t.co/cXYXDv1UgB” / Twitter. (n.d.). Retrieved February 2, 2022, from https://twitter.com/VikiLovesFACS/status/1487313040785686528

  5. Jan 2022
    1. Dr. Melvin Sanicas, #GetVaccinated. (2022, January 24). Smart people change their minds. They reconsider things they thought they’d already figure out when offered compelling data contradicting their previous understanding. Last week we saw the Swiss data. This is from #USA. #scicomm #dataviz #VaccinesSaveLives (h/t @OurWorldInData) https://t.co/Z5ONLNXr2u [Tweet]. @Vaccinologist. https://twitter.com/Vaccinologist/status/1485704680550412303

    1. Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2021). Risk of myocarditis following sequential COVID-19 vaccinations by age and sex (p. 2021.12.23.21268276). medRxiv. https://doi.org/10.1101/2021.12.23.21268276

    1. Stock, S. J., Carruthers, J., Calvert, C., Denny, C., Donaghy, J., Goulding, A., Hopcroft, L. E. M., Hopkins, L., McLaughlin, T., Pan, J., Shi, T., Taylor, B., Agrawal, U., Auyeung, B., Katikireddi, S. V., McCowan, C., Murray, J., Simpson, C. R., Robertson, C., … Wood, R. (2022). SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 1–9. https://doi.org/10.1038/s41591-021-01666-2

    1. Olson, S. M., Newhams, M. M., Halasa, N. B., Price, A. M., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Walker, T. C., Schwartz, S. P., Maddux, A. B., Mack, E. H., Bradford, T. T., Schuster, J. E., Nofziger, R. A., Cameron, M. A., Chiotos, K., Cullimore, M. L., Gertz, S. J., … Randolph, A. G. (2022). Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2117995